Semler Scientific, Inc. (SMLR)
USD 33.51
(-1.63%)
USD 33.51
(-1.63%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 20.58 Million USD | 43.69% |
| 2022 | 14.32 Million USD | -16.82% |
| 2021 | 17.22 Million USD | 22.95% |
| 2020 | 14 Million USD | -7.14% |
| 2019 | 15.08 Million USD | 200.84% |
| 2018 | 5.01 Million USD | 432.05% |
| 2017 | -1.51 Million USD | 40.88% |
| 2016 | -2.55 Million USD | 69.96% |
| 2015 | -8.5 Million USD | -88.28% |
| 2014 | -4.51 Million USD | -102.19% |
| 2013 | -2.23 Million USD | 18.53% |
| 2012 | -2.74 Million USD | -46.11% |
| 2011 | -1.87 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 6.07 Million USD | 43.88% |
| 2024 Q3 | 5.6 Million USD | 50890.91% |
| 2024 Q2 | 11 Thousand USD | -99.82% |
| 2023 Q2 | 5.87 Million USD | 18.31% |
| 2023 Q1 | 4.96 Million USD | 54.51% |
| 2023 FY | 20.58 Million USD | 43.69% |
| 2023 Q4 | 4.22 Million USD | -23.45% |
| 2023 Q3 | 5.51 Million USD | -6.21% |
| 2022 Q3 | 3.67 Million USD | -9.79% |
| 2022 Q4 | 3.21 Million USD | -12.49% |
| 2022 Q1 | 3.36 Million USD | 122.96% |
| 2022 FY | 14.32 Million USD | -16.82% |
| 2022 Q2 | 4.07 Million USD | 21.25% |
| 2021 Q1 | 4.87 Million USD | -9.57% |
| 2021 Q4 | 1.5 Million USD | -63.69% |
| 2021 Q2 | 6.68 Million USD | 37.13% |
| 2021 FY | 17.22 Million USD | 22.95% |
| 2021 Q3 | 4.15 Million USD | -37.95% |
| 2020 Q1 | 2.67 Million USD | -5.65% |
| 2020 Q2 | 1.07 Million USD | -59.78% |
| 2020 Q4 | 5.39 Million USD | 10.83% |
| 2020 FY | 14 Million USD | -7.14% |
| 2020 Q3 | 4.86 Million USD | 352.65% |
| 2019 Q3 | 7.77 Million USD | 197.02% |
| 2019 Q2 | 2.61 Million USD | 41.26% |
| 2019 Q4 | 2.83 Million USD | -63.58% |
| 2019 Q1 | 1.85 Million USD | 33.57% |
| 2019 FY | 15.08 Million USD | 200.84% |
| 2018 FY | 5.01 Million USD | 432.05% |
| 2018 Q4 | 1.38 Million USD | -5.45% |
| 2018 Q3 | 1.46 Million USD | 1.03% |
| 2018 Q2 | 1.45 Million USD | 105.81% |
| 2018 Q1 | 706 Thousand USD | 179.05% |
| 2017 Q1 | -871 Thousand USD | -295.91% |
| 2017 Q2 | -850 Thousand USD | 2.41% |
| 2017 Q3 | -41 Thousand USD | 95.18% |
| 2017 Q4 | 253 Thousand USD | 717.07% |
| 2017 FY | -1.51 Million USD | 40.88% |
| 2016 Q1 | -1 Million USD | 76.09% |
| 2016 FY | -2.55 Million USD | 69.96% |
| 2016 Q4 | -220 Thousand USD | 39.23% |
| 2016 Q3 | -362 Thousand USD | 62.53% |
| 2016 Q2 | -966 Thousand USD | 3.98% |
| 2015 Q4 | -4.2 Million USD | -166.33% |
| 2015 Q3 | -1.58 Million USD | -17.82% |
| 2015 FY | -8.5 Million USD | -88.28% |
| 2015 Q2 | -1.34 Million USD | 2.26% |
| 2015 Q1 | -1.37 Million USD | -14.33% |
| 2014 Q1 | -817 Thousand USD | -55.32% |
| 2014 Q3 | -1.46 Million USD | -42.05% |
| 2014 Q4 | -1.2 Million USD | 18.14% |
| 2014 FY | -4.51 Million USD | -102.19% |
| 2014 Q2 | -1.03 Million USD | -26.32% |
| 2013 Q4 | -526 Thousand USD | -0.57% |
| 2013 Q1 | -571 Thousand USD | 12.96% |
| 2013 FY | -2.23 Million USD | 18.53% |
| 2013 Q2 | -613 Thousand USD | -7.36% |
| 2013 Q3 | -523 Thousand USD | 14.68% |
| 2012 Q3 | -672 Thousand USD | 0.0% |
| 2012 Q4 | -656 Thousand USD | 2.38% |
| 2012 FY | -2.74 Million USD | -46.11% |
| 2011 FY | -1.87 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | -61.61 Million USD | 133.404% |
| BrainsWay Ltd. | -4.19 Million USD | 590.422% |
| Cerus Corporation | -37.48 Million USD | 154.904% |
| Envoy Medical, Inc. | -29.9 Million USD | 168.821% |
| electroCore, Inc. | -18.83 Million USD | 209.286% |
| Helius Medical Technologies, Inc. | -8.85 Million USD | 332.576% |
| IceCure Medical Ltd | -14.65 Million USD | 240.479% |
| Inogen, Inc. | -102.44 Million USD | 120.091% |
| OrthoPediatrics Corp. | -20.97 Million USD | 198.136% |
| Lucid Diagnostics Inc. | -52.66 Million USD | 139.082% |
| Monogram Orthopaedics, Inc. | -13.74 Million USD | 249.747% |
| MaxCyte, Inc. | -37.92 Million USD | 154.276% |
| NeuroOne Medical Technologies Corporation | -11.85 Million USD | 273.557% |
| Nexalin Technology, Inc. | -4.64 Million USD | 542.768% |
| Orthofix Medical Inc. | -151.39 Million USD | 113.596% |
| PAVmed Inc | -64.17 Million USD | 132.073% |
| Rapid Micro Biosystems, Inc. | -52.46 Million USD | 139.23% |
| RxSight, Inc. | -48.6 Million USD | 142.345% |
| Sight Sciences, Inc. | -55.54 Million USD | 137.055% |
| SI-BONE, Inc. | -43.33 Million USD | 147.496% |
| TELA Bio, Inc. | -46.66 Million USD | 144.109% |
| Treace Medical Concepts, Inc. | -49.52 Million USD | 141.559% |
| Vivos Therapeutics, Inc. | -13.58 Million USD | 251.535% |
| Acutus Medical, Inc. | -81.66 Million USD | 125.205% |
| Talis Biomedical Corporation | -62 Million USD | 133.195% |
| Spectral AI, Inc. | -20.85 Million USD | 198.7% |
| Nano-X Imaging Ltd. | -60.77 Million USD | 133.867% |
| CVRx, Inc. | -41.19 Million USD | 149.96% |
| DIH Holding US, Inc. Warrants | 640.19 Thousand USD | -3115.109% |
| PetVivo Holdings, Inc. | -10.95 Million USD | 287.882% |
| Bioventus Inc. | -156.23 Million USD | 113.175% |
| Venus Concept Inc. | -37.25 Million USD | 155.256% |
| TriSalus Life Sciences, Inc. | -59.03 Million USD | 134.864% |
| LivaNova PLC | 17.54 Million USD | -17.309% |
| 908 Devices Inc. | -36.39 Million USD | 156.548% |
| Alphatec Holdings, Inc. | -186.63 Million USD | 111.028% |
| Nemaura Medical Inc. | -14.14 Million USD | 245.527% |
| NeuroPace, Inc. | -32.95 Million USD | 162.456% |
| LENSAR, Inc. | -14.38 Million USD | 243.106% |
| Apyx Medical Corporation | -18.71 Million USD | 209.993% |
| Cutera, Inc. | -162.83 Million USD | 112.641% |
| STRATA Skin Sciences, Inc. | -10.83 Million USD | 290.055% |
| BioSig Technologies, Inc. | -29.04 Million USD | 170.876% |
| Anika Therapeutics, Inc. | -82.66 Million USD | 124.899% |
| ClearPoint Neuro, Inc. | -22.08 Million USD | 193.182% |
| Integra LifeSciences Holdings Corporation | 67.74 Million USD | 69.615% |
| Axonics, Inc. | -6.08 Million USD | 438.091% |
| Outset Medical, Inc. | -172.79 Million USD | 111.912% |
| IRIDEX Corporation | -9.57 Million USD | 315.078% |
| PROCEPT BioRobotics Corporation | -105.89 Million USD | 119.437% |
| IRadimed Corporation | 17.19 Million USD | -19.719% |
| Tivic Health Systems, Inc. | -8.24 Million USD | 349.672% |
| INVO Bioscience, Inc. | -8.03 Million USD | 356.179% |
| Telesis Bio, Inc. | -47.72 Million USD | 143.129% |
| Viemed Healthcare, Inc. | 10.24 Million USD | -100.947% |
| Varex Imaging Corporation | -47.7 Million USD | 143.151% |
| Quipt Home Medical Corp. | -2.78 Million USD | 839.332% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | 282.376% |
| Pulmonx Corporation | -60.84 Million USD | 133.83% |
| Dynatronics Corporation | -2.69 Million USD | 862.978% |
| Modular Medical, Inc. | -17.47 Million USD | 217.819% |
| ReShape Lifesciences Inc. | -11.38 Million USD | 280.759% |
| InMode Ltd. | 197.91 Million USD | 89.6% |
| Bruker Corporation | 427.2 Million USD | 95.182% |
| Cytosorbents Corporation | -28.5 Million USD | 172.202% |
| DexCom, Inc. | 541.5 Million USD | 96.199% |
| Align Technology, Inc. | 445.05 Million USD | 95.375% |
| Viveve Medical, Inc. | -22.02 Million USD | 193.444% |
| ZimVie Inc. | -393.28 Million USD | 105.234% |
| Movano Inc. | -29.28 Million USD | 170.29% |
| Cytek Biosciences, Inc. | -12.14 Million USD | 269.435% |
| Nexalin Technology, Inc. | -4.64 Million USD | 542.768% |
| DIH Holdings US, Inc. Class A Common Stock | 640.19 Thousand USD | -3115.109% |
| Tandem Diabetes Care, Inc. | -222.61 Million USD | 109.246% |
| Profound Medical Corp. | -28.56 Million USD | 172.047% |
| Insulet Corporation | 206.3 Million USD | 90.023% |
| enVVeno Medical Corporation | -23.51 Million USD | 187.528% |
| Surmodics, Inc. | -11.54 Million USD | 278.331% |
| iCAD, Inc. | -4.84 Million USD | 524.654% |
| Nuwellis, Inc. | -20.2 Million USD | 201.851% |
| Biotricity, Inc. | -14.09 Million USD | 246.038% |
| iRhythm Technologies, Inc. | -123.4 Million USD | 116.679% |
| Aethlon Medical, Inc. | -12.2 Million USD | 268.6% |
| InspireMD, Inc. | -19.91 Million USD | 203.349% |
| PAVmed Inc. | -64.17 Million USD | 132.073% |
| BIOLASE, Inc. | -20.63 Million USD | 199.763% |
| Beyond Air, Inc. | -60.24 Million USD | 134.167% |
| FONAR Corporation | 10.56 Million USD | -94.778% |
| AxoGen, Inc. | -21.71 Million USD | 194.783% |
| Vivani Medical, Inc. | -25.65 Million USD | 180.239% |
| Tactile Systems Technology, Inc. | 28.51 Million USD | 27.817% |
| Inari Medical, Inc. | -1.63 Million USD | 1358.13% |
| UFP Technologies, Inc. | 44.92 Million USD | 54.183% |
| QT Imaging Holdings, Inc. | -5.13 Million USD | 501.046% |
| Heart Test Laboratories, Inc. | -6.6 Million USD | 411.618% |
| Tenon Medical, Inc. | -15.58 Million USD | 232.103% |
| Autonomix Medical, Inc. Common Stock | -15.42 Million USD | 233.431% |
| Co-Diagnostics, Inc. | -35.33 Million USD | 158.255% |
| AdaptHealth Corp. | -678.89 Million USD | 103.032% |
| Sintx Technologies, Inc. | -8.25 Million USD | 349.219% |
| NanoVibronix, Inc. | -3.71 Million USD | 654.648% |
| Quanterix Corporation | -32.33 Million USD | 163.657% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | 282.376% |
| Sensus Healthcare, Inc. | 485 Thousand USD | -4143.918% |
| Pacific Biosciences of California, Inc. | -306.73 Million USD | 106.71% |
| TransMedics Group, Inc. | -25.02 Million USD | 182.24% |
| ReWalk Robotics Ltd. | -22.13 Million USD | 192.997% |
| NeuroMetrix, Inc. | -6.52 Million USD | 415.232% |
| Hyperfine, Inc. | -44.23 Million USD | 146.528% |
| Establishment Labs Holdings Inc. | -78.5 Million USD | 126.22% |
| Biomerica, Inc. | -5.97 Million USD | 444.312% |
| Bone Biologics Corporation | -8.94 Million USD | 330.01% |
| AVITA Medical, Inc. | -39.16 Million USD | 152.55% |
| Bluejay Diagnostics, Inc. | -9.95 Million USD | 306.784% |
| Silk Road Medical, Inc | -55.74 Million USD | 136.925% |